Abstract
Purpose
To provide an improved platform for simple, reliable, and cost-effective genotyping.
Background
Modern fertility treatments are becoming increasingly individualized in an attempt to optimise the follicular response and reproductive outcome, following controlled ovarian stimulation. As the field of pharmacogenetics evolve, genetic biomarkers such as polymorphisms of the follicle stimulating hormone receptor (FSHR) may be included as a predictive tool for individualized fertility treatment. However, the currently available genotyping methods are expensive, time-consuming or have a limited analytical sensitivity. Here, we present a novel version of “competitive amplification of differentially melting amplicons” (CADMA), providing an improved platform for simple, reliable, and cost-effective genotyping.
Methods
Two CADMA based assays were designed for the two common polymorphisms of the FSHR gene: rs6165 (c.919A > G, p. Thr307Ala, FSHR 307) and rs6166 (c.2039A > G, p. Asn680Ser, FSHR 680). To evaluate the reliability of the new CADMA-based assays, the genotyping results were compared with two conventional PCR based genotyping methods; allele-specific PCR (AS-PCR) and Sanger sequencing.
Results
The genotype frequencies for both polymorphisms were 35 % (TT), 42 % (CT), and 23 % (CC), respectively. A 100 % accordance was observed between the CADMA-based genotyping results and sequencing results, whereas 5 discrepancies were observed between the AS-PCR results and the CADMA-based genotyping results. Comparing the CADMA-based assays to (AS-PCR) and Sanger sequencing, the CADMA based assays showed an improved analytical sensitivity and a wider applicability.
Conclusions
The new assays provide a reliable, fast and user-friendly genotyping method facilitating a wider implication in clinical practise.
Similar content being viewed by others
References
Alviggi C et al. A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology. Reprod Biol Endocrinol. 2013;11:51.
Alviggi C, Humaidan P, Ezcurra D. Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols. Reprod Biol Endocrinol. 2012;10:9.
Behre HM et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics. 2005;15:451–6.
La Marca A et al. Polymorphisms in gonadotropin and gonadotropin receptor genes as markers of ovarian reserve and response in in vitro fertilization. Fertil Steril. 2013;99:970–8.
Laan M, Grigorova M, Huhtaniemi IT. Pharmacogenetics of follicle-stimulating hormone action. Curr Opin Endocrinol Diabetes Obes. 2012;19:220–7.
Simoni M, Casarini L. Potential for pharmacogenetic use of FSH: a 2014-and-beyond view. Endocrinol: Eur. J; 2013.
Desai SS et al. Association of allelic combinations of FSHR gene polymorphisms with ovarian response. Reprod Biomed Online. 2013;27:400–6.
Klinkert ER et al. FSH receptor genotype is associated with pregnancy but not with ovarian response in IVF. Reprod Biomed Online. 2006;13:687–95.
Lazaros L et al. Influence of FSHR diplotypes on ovarian response to standard gonadotropin stimulation for IVF/ICSI. J Reprod Med. 2013;58:395–401.
Lledo B et al. Effect of follicle-stimulating hormone receptor N680S polymorphism on the efficacy of follicle-stimulating hormone stimulation on donor ovarian response. Pharmacogenet Genomics. 2013;23:262–8.
Perez MM et al. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab. 2000;85:3365–9.
Yan Y. Association of follicle-stimulating hormone receptor polymorphisms with ovarian response in Chinese women: a prospective clinical study. PLoSOne. 2013;8:e78138.
Yao Y, Ma CH, Tang HL, Hu YF. Influence of follicle-stimulating hormone receptor (FSHR) Ser680Asn polymorphism on ovarian function and in-vitro fertilization outcome: a meta-analysis. Mol Genet Metab. 2011;103:388–93.
Boudjenah R. Genetic polymorphisms influence the ovarian response to rFSH stimulation in patients undergoing in vitro fertilization programs with ICSI. PLoSOne. 2012;7:e38700.
Kristensen LS, Andersen GB, Hager H, Hansen LL. Competitive amplification of differentially melting amplicons (CADMA) enables sensitive and direct detection of all mutation types by high-resolution melting analysis. Hum Mutat. 2012;33:264–71.
Kristensen LS, Kjeldsen TE, Hager H, Hansen LL. Competitive amplification of differentially melting amplicons (CADMA) improves KRAS hotspot mutation testing in colorectal cancer. BMC Cancer. 2012;12:548.
Lindgren I, Giwercman A, Axelsson J, Lundberg GY. Association between follicle-stimulating hormone receptor polymorphisms and reproductive parameters in young men from the general population. Pharmacogenet Genomics. 2012;22:667–72.
Gromoll J, Simoni M. Genetic complexity of FSH receptor function. Trends Endocrinol Metab. 2005;16:368–73.
La MA et al. The combination of genetic variants of the FSHB and FSHR genes affects serum FSH in women of reproductive age. Hum Reprod. 2013;28:1369–74.
Kwok S, Chang SY, Sninsky JJ, Wang A. A guide to the design and use of mismatched and degenerate primers. PCR Methods Appl. 1994;3:S39–47.
Morlan J, Baker J, Sinicropi D. Mutation detection by real-time PCR: a simple, robust and highly selective method. PLoSOne. 2009;4:e4584.
Wittwer CT, Reed GH, Gundry CN, Vandersteen JG, Pryor RJ. High-resolution genotyping by amplicon melting analysis using LCGreen. Clin Chem. 2003;49:853–60.
Gundry CN et al. Base-pair neutral homozygotes can be discriminated by calibrated high-resolution melting of small amplicons. Nucleic Acids Res. 2008;36:3401–8.
Kristensen LS, Dobrovic A. Direct genotyping of single nucleotide polymorphisms in methyl metabolism genes using probe-free high-resolution melting analysis. Cancer Epidemiol Biomarkers Prev. 2008;17:1240–7.
De La Vega FM, Lazaruk KD, Rhodes MD, Wenz MH. Assessment of two flexible and compatible SNP genotyping platforms: TaqMan SNP Genotyping Assays and the SNPlex Genotyping System. Mutat Res. 2005;573:111–35.
Casarini L, Pignatti E, Simoni M. Effects of polymorphisms in gonadotropin and gonadotropin receptor genes on reproductive function. Rev Endocr Metab Disord. 2011;12:303–21.
Acknowledgments
The authors would like to acknowledge Yvonne Giwercman from Molecular Genetic Reproductive Medicine, Department of Clinical Sciences, Faculty of Medicine, Lund University, Malmö, Sweden, for providing reference DNA of known genotypes, as well as AS-PCR assays the FSHR polymorphisms rs6165 and rs6166.
Source of funding
This work was supported by the faculty of Health, University of Aarhus, and by ReproHigh, an Interregional EU project.
Conflicts of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
ESM 1
(PDF 176 kb)
Fig. S1
False-positive amplification using AS-PCR. We encountered recurrent problems with uneven amplification (left panel) and false-positive amplification (mid and right panel), when genotyping with AS-PCR. Each assay consists of two PCR runs, one for each genotype, containing a PCR control fragment (CF; upper band) and a genotype specific fragment (GF; lower band). The presence of a lower band marks the genotype. As the two polymorphisms are in linkage disequilibrium, the genotype of FSHR 307 should match the genotype of FSHR 680. (GIF 333 kb)
Rights and permissions
About this article
Cite this article
Borgbo, T., Sommer Kristensen, L., Lindgren, I. et al. Genotyping common FSHR polymorphisms based on competitive amplification of differentially melting amplicons (CADMA).. J Assist Reprod Genet 31, 1427–1436 (2014). https://doi.org/10.1007/s10815-014-0329-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-014-0329-6